Angiosyn
La Jolla
About Angiosyn
Angiosyn, Inc. is a biopharmaceutical company developing novel proprietary biologics for controlling angiogenesis. The company's initial therapeutic indication is for ophthalmic diseases, such as macular degeneration and diabetic retinopathy, which due to angiogenesis can lead to decreased vision and blindness
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: angiosyn.com
- Phone: [email protected]
Canonical: https://fsome.com/organization/angiosyn-2318637 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.